Bonesupport Holding Future Growth
Future criteria checks 6/6
Bonesupport Holding is forecast to grow earnings and revenue by 31.2% and 33.8% per annum respectively. EPS is expected to grow by 30.8% per annum. Return on equity is forecast to be 39.6% in 3 years.
Key information
31.2%
Earnings growth rate
30.8%
EPS growth rate
| Biotechs earnings growth | 36.7% |
| Revenue growth rate | 33.8% |
| Future return on equity | 39.6% |
| Analyst coverage | Low |
| Last updated | 28 Jul 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,865 | 569 | 414 | 438 | 1 |
| 12/31/2025 | 1,297 | 293 | 279 | 250 | 3 |
| 12/31/2024 | 893 | 119 | -21 | -3 | 3 |
| 6/30/2024 | 735 | 289 | -29 | -21 | N/A |
| 3/31/2024 | 656 | 267 | 0 | 7 | N/A |
| 12/31/2023 | 591 | 245 | -24 | -18 | N/A |
| 9/30/2023 | 522 | 214 | -40 | -37 | N/A |
| 6/30/2023 | 448 | -30 | -66 | -63 | N/A |
| 3/31/2023 | 382 | -51 | -51 | -48 | N/A |
| 12/31/2022 | 329 | -68 | -50 | -47 | N/A |
| 9/30/2022 | 287 | -72 | -62 | -58 | N/A |
| 6/30/2022 | 257 | -71 | -72 | -68 | N/A |
| 3/31/2022 | 234 | -82 | -81 | -77 | N/A |
| 12/31/2021 | 213 | -86 | -87 | -83 | N/A |
| 9/30/2021 | 205 | -88 | -90 | -88 | N/A |
| 6/30/2021 | 198 | -96 | -89 | -87 | N/A |
| 3/31/2021 | 182 | -92 | -88 | -86 | N/A |
| 12/31/2020 | 181 | -101 | -103 | -100 | N/A |
| 9/30/2020 | 174 | -115 | -121 | -117 | N/A |
| 6/30/2020 | 165 | -127 | -143 | -139 | N/A |
| 3/31/2020 | 166 | -151 | -155 | -150 | N/A |
| 12/31/2019 | 155 | -161 | -168 | -164 | N/A |
| 9/30/2019 | 132 | -166 | -181 | -176 | N/A |
| 6/30/2019 | 108 | -191 | -193 | -189 | N/A |
| 3/31/2019 | 98 | -182 | -180 | -177 | N/A |
| 12/31/2018 | 97 | -176 | -174 | -172 | N/A |
| 9/30/2018 | 101 | -182 | -152 | -147 | N/A |
| 6/30/2018 | 119 | -146 | -133 | -128 | N/A |
| 3/31/2018 | 128 | -132 | N/A | -112 | N/A |
| 12/31/2017 | 129 | -129 | N/A | -108 | N/A |
| 9/30/2017 | 132 | -112 | N/A | -112 | N/A |
| 6/30/2017 | 126 | -124 | N/A | -106 | N/A |
| 3/31/2017 | 114 | -124 | N/A | -103 | N/A |
| 12/31/2016 | 105 | -110 | N/A | -82 | N/A |
| 12/31/2015 | 62 | -60 | N/A | -65 | N/A |
| 12/31/2014 | 41 | -75 | N/A | -46 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0RQO's forecast earnings growth (31.2% per year) is above the savings rate (1.9%).
Earnings vs Market: 0RQO's earnings (31.2% per year) are forecast to grow faster than the UK market (14.4% per year).
High Growth Earnings: 0RQO's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 0RQO's revenue (33.8% per year) is forecast to grow faster than the UK market (3.7% per year).
High Growth Revenue: 0RQO's revenue (33.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0RQO's Return on Equity is forecast to be high in 3 years time (39.6%)